Exenatide and placebo groups were matched for age (mean (standard deviation (SD) age of exenatide group 28 (13) years, placebo group 28 (6) years) and body mass index (BMI) (exenatide group 37.6 (7.9) kg/m 2 , placebo group 38.6 (4.7) kg/m 2 )
A continuacin, se enumeran los tratamientos recomendados habitualmente para nios con CTD: 1
GH has several effects on the body, including a glucose-sparing effect, meaning that instead of the body utilizing glucose as a primary energy source, the body taps into adipose tissue, using stored fat as energy
Their combination produces synergistic GH release greater than either alone
For most people, the initial adjustment period represents the highest-risk window, and it passes relatively quickly with proper management